Involvement of P2X1 and P2X2 purinergic receptors in motoneuron response to injury was investigated with Western blotting and immunohistochemistry and correlated with motoneuron loss, Bcl-2 expression, nitric oxide synthase induction and glial activation. P2X1 was highly induced in rat facial motoneurons after nerve resection, which causes slowly occurring neurodegeneration. P2X1 induction was lower and less persistent after nerve crush, permissive for fiber regeneration. P2X2 expression was found in nuclei of rat facial motoneurons, with nuclear export in the cytoplasm after nerve resection. P2X1 induction in axotomized facial motoneurons was impaired in superoxide dismutase (SOD)1-G93A-mutant mice, a model of motoneuron disease. The data in rats point to a correlation of P2X1 induction with motoneuron degeneration, which also involves P2X2 intracellular changes, rather than with axon regeneration effort. The data in mice show that the SOD1 mutation interferes with injury-elicited P2X1 induction, suggesting alterations of ATP release from mutant motoneurons after damage.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.nbd.2006.08.020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Fucosidosis: A Review of a Rare Disease.
Int J Mol Sci
January 2025
Department of Molecular Biology and Genetics, Çanakkale Onsekiz Mart University, Çanakkale 17100, Turkey.
Fucosidosis is a rare lysosomal storage disease caused by α-L-fucosidase deficiency following a mutation in the gene. This enzyme is responsible for breaking down fucose-containing glycoproteins, glycolipids, and oligosaccharides within the lysosome. Mutations in result in either reduced enzyme activity or complete loss of function, leading to the accumulation of fucose-rich substrates in lysosomes.
View Article and Find Full Text PDFBotulinum toxin modulates the blink reflex via the trigeminal afferent system in hemifacial spasm: an early and late-term effect.
Neurol Sci
December 2024
Department of Neurology, Section of Clinical Neurophysiology, Faculty of Medicine, Gazi University, Ankara, Turkey.
Background: There is growing evidence that botulinum neurotoxin (BoNT) can mediate changes at the central level through peripheral mechanisms, leading to alterations in central sensorimotor integration. However, the effect of BoNT on brainstem excitability in patients with hemifacial spasm(HFS) is not yet fully understood, and its long-term effects remain unknown.
Objective: This study aims to investigate the impact of BoNT on the excitability of the facial nucleus in patients with idiopathic HFS.
Capsaicin-Loaded Melanin Nanoparticles for Long-Lasting Nociceptive-Selective Nerve Blockade.
Langmuir
November 2024
Department of Chemical and Biological Engineering, University of Alabama, Tuscaloosa, Alabama 35487, United States.
Article Synopsis
- Clinically used local anesthetics like bupivacaine and lidocaine have issues with short duration and affecting both pain and motor functions, leading to unwanted muscle weakness.
- Researchers developed capsaicin-loaded melanin nanoparticles (Cap-MNPs) that selectively target sensory neurons, aiming for effective pain relief without impacting motor function.
- Cap-MNPs demonstrated high drug loading efficiency and sustained release, providing a 6-hour sciatic sensory nerve block in rats without local or systemic toxicity, suggesting potential for future clinical pain management.
Optimizing TDP-43 silencing with siRNA-loaded polymeric nanovectors in neuronal cells for therapeutic applications: balancing knockdown and function.
Nanoscale
December 2024
Nanotechnology Institute, CNR-NANOTEC, Monteroni street, 73100 Lecce, Italy.
TAR DNA-binding protein 43 (TDP-43) is a ubiquitously expressed DNA/RNA binding protein critical for regulating gene expression, including transcription, splicing, mRNA stability, and protein translation. Aggregation of pathological TDP-43 proteins in the cytoplasm of neurons and glial cells appears to be a common feature of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases such as frontotemporal dementia (FTD), contributing to motor neuron degeneration and clinical symptoms. Downregulation of TDP-43 expression to prevent or reduce the formation of pathological aggregates is a potential therapeutic approach for treating TDP-43-related diseases.
View Article and Find Full Text PDFFucoidan-derived carbon dots as nanopenetrants of blood-brain barrier for Parkinson's disease treatment.
J Colloid Interface Sci
February 2025
Qingdao Key Laboratory of Materials for Tissue Repair and Rehabilitation, Shandong Engineering Research Center for Tissue Rehabilitation Materials and Devices, School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, Qingdao 266113, China. Electronic address:
Parkinson's Disease (PD) stands as a prevalent neurodegenerative disorder. However, current pharmacotherapies for PD face challenges due to inadequate penetration through the blood-brain barrier (BBB), posing limitations on their therapeutic efficacy. Considering the potential of negatively charged carbon dots (CDs) in retaining functional groups from precursor molecules and vertically crossing the BBB, this study focuses on the utilization of fucoidan (FD), a promising pharmaceutical candidate with neuroprotective effects on dopamine-active neurons, for the development of negatively charged CDs through a one-step hydrothermal method, aiming to achieve efficient BBB penetration for PD treatment.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!